|
Name |
Hexyl isovalerate
|
Molecular Formula | C11H22O2 | |
IUPAC Name* |
hexyl 3-methylbutanoate
|
|
SMILES |
CCCCCCOC(=O)CC(C)C
|
|
InChI |
InChI=1S/C11H22O2/c1-4-5-6-7-8-13-11(12)9-10(2)3/h10H,4-9H2,1-3H3
|
|
InChIKey |
RSDDTPVXLMVLQE-UHFFFAOYSA-N
|
|
Synonyms |
Hexyl isovalerate; Hexyl 3-methylbutanoate; 10032-13-0; Butanoic acid, 3-methyl-, hexyl ester; Hexyl isopentanoate; n-Hexyl isopentanoate; Isovaleric acid, hexyl ester; 10632-13-0; Hexyl isovaleriate; Hexyl isovalerianate; Hexyl 3-methyl butanoate; 3-Methylbutyric acid hexyl ester; n-Hexyl iso-valerate; FEMA No. 3500; HEXYL ISOVALERATE STANDARD FOR GC; Hexyl 3-methylbutyrate; 5FJ2M7YCY6; Hexyl 3-methylbutanoate (natural); EINECS 233-105-7; UNII-5FJ2M7YCY6; BRN 1759161; AI3-33585; Caproyl isovalerate; 1-Hexanol isovalerate; Hexyl 3-methyl butyrate; SCHEMBL573930; HEXYL ISOVALERATE [FCC]; DTXSID4064921; HEXYL ISOVALERATE [FHFI]; FEMA 3500; 3-Methylbutanoic acid hexyl ester; CHEBI:179380; Hexyl 3-methylbutanoate, >=99%; ZINC1850757; Isovaleric acid, hexyl ester (8CI); LMFA07010908; FT-0627062; FT-0693397; J-000099; Q27261969
|
|
CAS | 10032-13-0 | |
PubChem CID | 61455 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 186.29 | ALogp: | 3.7 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 13 | QED Weighted: | 0.444 |
Caco-2 Permeability: | -4.319 | MDCK Permeability: | 0.00002700 |
Pgp-inhibitor: | 0.04 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.676 |
30% Bioavailability (F30%): | 0.855 |
Blood-Brain-Barrier Penetration (BBB): | 0.847 | Plasma Protein Binding (PPB): | 90.52% |
Volume Distribution (VD): | 0.599 | Fu: | 10.78% |
CYP1A2-inhibitor: | 0.956 | CYP1A2-substrate: | 0.355 |
CYP2C19-inhibitor: | 0.788 | CYP2C19-substrate: | 0.483 |
CYP2C9-inhibitor: | 0.703 | CYP2C9-substrate: | 0.771 |
CYP2D6-inhibitor: | 0.011 | CYP2D6-substrate: | 0.076 |
CYP3A4-inhibitor: | 0.096 | CYP3A4-substrate: | 0.187 |
Clearance (CL): | 11.967 | Half-life (T1/2): | 0.634 |
hERG Blockers: | 0.055 | Human Hepatotoxicity (H-HT): | 0.028 |
Drug-inuced Liver Injury (DILI): | 0.333 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.07 | Maximum Recommended Daily Dose: | 0.012 |
Skin Sensitization: | 0.913 | Carcinogencity: | 0.258 |
Eye Corrosion: | 0.979 | Eye Irritation: | 0.988 |
Respiratory Toxicity: | 0.23 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000570 | 0.628 | D0AY9Q | 0.481 | ||||
ENC000726 | 0.600 | D01QLH | 0.357 | ||||
ENC000655 | 0.581 | D05ATI | 0.302 | ||||
ENC000228 | 0.558 | D06ORU | 0.276 | ||||
ENC000718 | 0.558 | D0G2KD | 0.276 | ||||
ENC000241 | 0.526 | D0Z5SM | 0.271 | ||||
ENC000459 | 0.512 | D0H2YX | 0.269 | ||||
ENC000742 | 0.510 | D0X4FM | 0.264 | ||||
ENC000448 | 0.500 | D05PLH | 0.262 | ||||
ENC000231 | 0.488 | D00WUF | 0.260 |